Biocure Technology Inc.

    Biocure Technology Inc.

    CCSE:CURE
    - -
    CAD
    - -
    - -
    Biocure Technology Inc.
    CSE:CURE
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2012
    2013
    2014
    2015
    2016
    2016
    2017
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -0.03
    -0.01
    0.01
    -0.02
    -0.02
    -0.42
    - -
    -0.46
    -0.62
    -0.44
    -0.27
    -0.1
    -0.12
    -0.18
    -0.03
    -0.01
    -0.01
    Basic EPS, GAAP
    -0.07
    -0.02
    -0.01
    -0.01
    -0.01
    -0.29
    -0.01
    -0.22
    -0.33
    -0.35
    -0.12
    -0.09
    -0.07
    -0.02
    - -
    - -
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.47
    0.46
    0.44
    0.42
    0.41
    -0.06
    0.39
    0.28
    0.08
    -0.03
    -0.18
    -0.04
    -0.16
    0.15
    0.13
    0.08
    0.08
    Book Value per Share
    0.47
    0.46
    0.44
    0.42
    0.41
    -0.06
    0.39
    0.28
    0.08
    -0.03
    -0.18
    -0.05
    -0.16
    0.15
    0.13
    0.08
    0.08
    Tangible Book Value per Share
    3
    4
    4
    4
    4
    5
    5
    10
    11
    11
    11
    11
    12
    10
    10
    16
    13
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    -17,053.71
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    -2
    - -
    -5
    -7
    -5
    -3
    -1
    -1
    -2
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    -35,299.35
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -2
    -2
    -4
    -2
    -4
    - -
    -1
    - -
    - -
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    3
    3
    1
    - -
    - -
    - -
    - -
    - -
    LT Debt
    2
    2
    2
    2
    2
    - -
    2
    3
    1
    - -
    -2
    -1
    -2
    2
    1
    2
    2
    Total Equity
    - -
    - -
    -4.4
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    1.97
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    -6.73
    -1.87
    1.96
    -4.43
    -3.88
    - -
    - -
    -200.79
    -348.32
    - -
    - -
    - -
    - -
    - -
    -17.83
    -7.05
    -7.05
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    15
    20
    20
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    CAD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    - -
    - -
    Payables & Accruals
    1
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -54.33%
    -11.55%
    17.55%
    Free Cash Flow
    298.37%
    -175.94%
    -658%
    Net Income, GAAP
    5,444.99%
    -30.88%
    -60.81%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    -0.03
    2025
    - -
    - -
    - -
    - -
    -0.01
    2026
    - -
    -0.11
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business